Results 341 to 350 of about 749,882 (394)

[Retracted] Renal denervation attenuates cardiac hypertrophy in spontaneously hypertensive rats via regulation of autophagy. [PDF]

Mol Med Rep
Huang J, Huang H, Pan W, Ou D, Dai W, Lin Y, Wu J, Xie W, Chen X.   +8 more
europepmc   +1 more source

Use of artificial intelligence for detecting left ventricular dysfunction and predicting incident heart failure risk

ESC Heart Failure, EarlyView.
Abstract Effective medications are available for the prevention of heart failure (HF). While their use is indicated in patients with risk factors, engagement and adherence among ‘at risk’ individuals is challenging, as it is with atherosclerotic heart disease prevention.
Anna Węgrzyn‐Witek, Monika Przewlocka‐Kosmala, Wojciech Kosmala, Thomas H. Marwick   +3 more
wiley   +1 more source

Isolated bilateral temporalis hypertrophy: a rare case report and technical insight into botulinum toxin type A injection. [PDF]

J Korean Assoc Oral Maxillofac Surg
Aktaş S, Uranbey Ö, Gürsoytrak B.
europepmc   +1 more source

The Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis

European Journal of Heart Failure, EarlyView.
Proposed algorithm to screen for transthyretin cardiac amyloidosis (ATTR‐CA). AL‐CA, immunoglobulin light‐chain cardiac amyloidosis; AMYLI, AMYLoidosis Index; AUC, area under the curve; IWT, increased wall thickness; LVEF, left ventricular ejection fraction; PYP, pyrophosphate.
Giovanni Battista Bonfioli, Daniela Tomasoni, Giuseppe Vergaro, Vincenzo Castiglione, Marianna Adamo, Iacopo Fabiani, Victor Loghin, Carlo Mario Lombardi, Alessio Nicolai, Marco Metra, Michele Emdin, Alberto Aimo   +11 more
wiley   +1 more source

Cardiac Myosin Inhibitors in Hypertrophic Cardiomyopathy: From Sarcomere to Clinic. [PDF]

Int J Mol Sci
Nakamura K, Okumura T, Kato S, Onoue K, Kubo T, Kouzu H, Yano T, Inomata T.   +7 more
europepmc   +1 more source

Dietary Nitrate Prevents Cardiac Dysfunction in HFrEF by Improving Hemodynamics, Ameliorating Remodeling, and Resolving Inflammation. [PDF]

Acta Physiol (Oxf)
Shimari M, Picozzi G, Boeder A, Guimarães DD, Zhuge Z, Lundberg JO, Carlstrom M, Lund LH, Andersson DC, Pironti G.   +9 more
europepmc   +1 more source

Age-stratified reference ranges for adenoid hypertrophy in children: a single-center retrospective study. [PDF]

Front Pediatr
Tao E, Liang W, Gu H, Zhou J, Zheng C, Yuan J.   +5 more
europepmc   +1 more source

Evaluation of Oral Health and Oral Health-Related Quality of Life in Children with Adenoid Hypertrophy. [PDF]

Children (Basel)
Kılıç MÇ, Cantekin K, Haylaz E, Kalabalık F, Kılıç K, Bircan HB, Güner M.   +6 more
europepmc   +1 more source

Single-cell RNA sequencing reveals that myeloid S100A8/A9 is a novel regulator of the transition from adaptive hypertrophy to heart failure after pressure overload. [PDF]

Theranostics
Yu WJ, Jiang WX, Liu SJ, Li HH, Lin QY.
europepmc   +1 more source

Corrigendum to "Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses". [PDF]

Cardiovasc Ther
europepmc   +1 more source